JPWO2021022008A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021022008A5 JPWO2021022008A5 JP2022506419A JP2022506419A JPWO2021022008A5 JP WO2021022008 A5 JPWO2021022008 A5 JP WO2021022008A5 JP 2022506419 A JP2022506419 A JP 2022506419A JP 2022506419 A JP2022506419 A JP 2022506419A JP WO2021022008 A5 JPWO2021022008 A5 JP WO2021022008A5
- Authority
- JP
- Japan
- Prior art keywords
- drawings
- present application
- invention described
- application
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Claims (1)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962880547P | 2019-07-30 | 2019-07-30 | |
US62/880,547 | 2019-07-30 | ||
US202062990318P | 2020-03-16 | 2020-03-16 | |
US62/990,318 | 2020-03-16 | ||
PCT/US2020/044196 WO2021022008A1 (en) | 2019-07-30 | 2020-07-30 | Virus-like particle vaccines |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2022543046A JP2022543046A (en) | 2022-10-07 |
JPWO2021022008A5 true JPWO2021022008A5 (en) | 2023-08-07 |
Family
ID=74228282
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022506419A Pending JP2022543046A (en) | 2019-07-30 | 2020-07-30 | virus-like particle vaccine |
Country Status (7)
Country | Link |
---|---|
US (2) | US20220280633A1 (en) |
EP (1) | EP4004036A4 (en) |
JP (1) | JP2022543046A (en) |
CN (1) | CN114729030A (en) |
AU (1) | AU2020321021A1 (en) |
CA (1) | CA3149390A1 (en) |
WO (1) | WO2021022008A1 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3114699A1 (en) | 2018-10-09 | 2020-04-16 | The University Of British Columbia | Compositions and systems comprising transfection-competent vesicles free of organic-solvents and detergents and methods related thereto |
WO2022008973A2 (en) * | 2020-07-10 | 2022-01-13 | Covid Diagnostics Ltd. | Compositions, methods, and systems for detecting immune response |
CN112760420B (en) * | 2021-02-05 | 2023-05-26 | 中国科学院长春应用化学研究所 | Primer, probe and kit for detecting novel coronavirus SARS-CoV-2 |
CN114957409A (en) * | 2021-02-26 | 2022-08-30 | 中国科学院上海巴斯德研究所 | Method and product for coronavirus intervention based on S protein R815 locus |
WO2022191742A1 (en) * | 2021-03-11 | 2022-09-15 | Dukhovlinov Ilya Vladimirovich | A method for assessment of the cellular immune |
CA3218711A1 (en) * | 2021-05-13 | 2022-11-17 | Roee Amit | Methods and compositions for treatment of viral infection |
WO2022261355A1 (en) * | 2021-06-09 | 2022-12-15 | Chimeron Bio Corporation | Self-amplifying rna-based vlp vaccines |
WO2023023597A1 (en) * | 2021-08-18 | 2023-02-23 | Nanored Llc | Virus-like particle |
IL310010A (en) * | 2021-09-09 | 2024-03-01 | Universit?T Basel | Biologically produced nucleic acid for vaccine production |
WO2023062651A1 (en) * | 2021-10-13 | 2023-04-20 | Padmanabh Patil Harshad | Virus-like particles for respiratory syncytial virus and method of preparation thereof |
RU2769224C1 (en) * | 2021-12-30 | 2022-03-29 | федеральное государственное бюджетное учреждение «Национальный исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи» Министерства здравоохранения Российской Федерации | Recombinant virus-like particles for induction of specific immunity against severe acute respiratory syndrome virus sars-cov-2 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE489969T1 (en) * | 2002-06-20 | 2010-12-15 | Cytos Biotechnology Ag | PACKAGED VIRUS-LIKE PARTICLES IN COMBINATION WITH CPG FOR USE AS ADJUVANTS WITH ALLERGENS. MANUFACTURING PROCESS AND USE |
US20100015218A1 (en) * | 2007-02-16 | 2010-01-21 | Vasant Jadhav | Compositions and methods for potentiated activity of biologically active molecules |
WO2011002522A2 (en) * | 2009-07-02 | 2011-01-06 | Medimmune, Llc | Methods of making and using synthetic viruses |
CN103154251A (en) * | 2010-09-30 | 2013-06-12 | 佛兰瓦克斯有限责任公司 | Generation of virosome particles |
PL2811981T3 (en) * | 2012-02-07 | 2019-09-30 | Infectious Disease Research Institute | Improved adjuvant formulations comprising tlr4 agonists and methods of using the same |
US10829543B2 (en) * | 2012-10-29 | 2020-11-10 | The University Of North Carolina At Chapel Hill | Compositions and methods for inhibiting pathogen infection |
WO2016039620A2 (en) * | 2014-09-12 | 2016-03-17 | Bestewil Holding B.V. | Respiratory syncytial virus virosomes |
US10676511B2 (en) * | 2015-09-17 | 2020-06-09 | Ramot At Tel-Aviv University Ltd. | Coronaviruses epitope-based vaccines |
-
2020
- 2020-07-30 US US17/631,435 patent/US20220280633A1/en active Pending
- 2020-07-30 WO PCT/US2020/044196 patent/WO2021022008A1/en unknown
- 2020-07-30 CA CA3149390A patent/CA3149390A1/en active Pending
- 2020-07-30 EP EP20847900.6A patent/EP4004036A4/en active Pending
- 2020-07-30 CN CN202080066460.8A patent/CN114729030A/en active Pending
- 2020-07-30 JP JP2022506419A patent/JP2022543046A/en active Pending
- 2020-07-30 AU AU2020321021A patent/AU2020321021A1/en active Pending
-
2022
- 2022-01-28 US US17/588,008 patent/US20230000974A1/en active Pending